Maria Tengström

发表

Association analysis identifies 65 new breast cancer risk loci

Gary D Bader, Jaana M. Hartikainen, Jeffery M. Meyer, 2017, Nature.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Jane E. Carpenter, Jaana M. Hartikainen, W. Chung, 2019, Nature Genetics.

Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

Peter Kraft, Michael Bremer, Simon S. Cross, 2008, PLoS genetics.

SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?

A. Mannermaa, V. Kosma, V. Kataja, 2012, BMC Cancer.

Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

Jack A. Taylor, W. Chung, S. Cross, 2019, bioRxiv.

High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival

A. Mannermaa, V. Kosma, Maria Tengström, 2021, Cancers.

Predicting breast cancer risk using interacting genetic and demographic factors and machine learning

A. Mannermaa, V. Kosma, J. Hartikainen, 2020, Scientific Reports.

Genome-wide association study of germline variants and breast cancer-specific mortality

A. Whittemore, W. Willett, S. Cross, 2019, British Journal of Cancer.

Genetic polymorphisms and protein expression of NRF2 and Sulfiredoxin predict survival outcomes in breast cancer.

Jaana M. Hartikainen, A. Mannermaa, V. Kosma, 2012, Cancer research.

XRCC 1 rs 25487 Polymorphism Predicts the Survival of Patients After Postoperative Radiotherapy and Adjuvant Chemotherapy for Breast Cancer

A. Mannermaa, V. Kosma, V. Kataja, 2014 .

Kathleen Cuningham Foundation Consortium For Research Into Familial Breast Cancer

A. Uitterlinden, S. Cross, C. Vachon, 2008 .

Genome-wide association study of germline variants and breast cancer-speci ﬁ c mortality

A. Whittemore, M. Beckmann, A. Talhouk, 2019 .

FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome

Sofia Khan, H. Nevanlinna, R. Fagerholm, 2016, International journal of cancer.

Genome-wide association study of germline variants and breast cancer-specific mortality

A. Whittemore, W. Willett, S. Cross, 2019, British Journal of Cancer.

FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population

Sofia Khan, J. Schleutker, Å. Borg, 2017, Breast Cancer Research and Treatment.

Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility

J. Schleutker, Å. Borg, H. Nevanlinna, 2017, Scientific Reports.

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Michael Jones, Peter Kraft, Arnaud Droit, 2017, Nature Genetics.

The debatable presence of PIWI‐interacting RNAs in invasive breast cancer

Jaana M. Hartikainen, A. Mannermaa, V. Kosma, 2021, Cancer medicine.

Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls

Hamid Behravan, Katri Pylkäs, Arto Mannermaa, 2018, Scientific Reports.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2019, Nature Genetics.

Expression profiles of small non-coding RNAs in breast cancer tumors characterize clinicopathological features and show prognostic and predictive potential

Jaana M. Hartikainen, A. Mannermaa, V. Kosma, 2022, Scientific Reports.

E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium

J. Olson, F. Couch, H. Brenner, 2018, Scientific Reports.

Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

S. Cross, M. Beckmann, P. Fasching, 2020, American journal of human genetics.

Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival

A. Mannermaa, V. Kosma, V. Kataja, 2015, BMC Cancer.

Histone demethylase GASC1 - a potential prognostic and predictive marker in invasive breast cancer

A. Mannermaa, V. Kosma, K. Nieminen, 2012, BMC Cancer.

Type II Transmembrane Serine Protease Gene Variants Associate with Breast Cancer

A. Mannermaa, V. Kosma, V. Kataja, 2014, PloS one.

Circulating Cell-Free DNA Reflects the Clonal Evolution of Breast Cancer Tumors

A. Mannermaa, V. Kosma, J. Hartikainen, 2022, Cancers.

High mutation burden of circulating cell‐free DNA in early‐stage breast cancer patients is associated with a poor relapse‐free survival

A. Mannermaa, V. Kosma, J. Hartikainen, 2020, Cancer medicine.

Title : Histone demethylase GASC 1-a potential prognostic and predictive marker in invasive breast cancer

A. Mannermaa, V. Kosma, K. Nieminen, 2012 .

XRCC1 rs25487 polymorphism predicts the survival of patients after postoperative radiotherapy and adjuvant chemotherapy for breast cancer.

A. Mannermaa, V. Kosma, V. Kataja, 2014, Anticancer research.

Predicting breast cancer risk using interacting genetic and demographic factors and machine learning

A. Mannermaa, V. Kosma, J. Hartikainen, 2020, Scientific Reports.

KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes

Jaana M. Hartikainen, A. Mannermaa, V. Kosma, 2015, Clinical Cancer Research.

Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival

A. Mannermaa, V. Kosma, V. Kataja, 2015, BMC Cancer.